1. Home
  2. UNCY vs SLNG Comparison

UNCY vs SLNG Comparison

Compare UNCY & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • SLNG
  • Stock Information
  • Founded
  • UNCY 2016
  • SLNG 2013
  • Country
  • UNCY United States
  • SLNG United States
  • Employees
  • UNCY N/A
  • SLNG N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • SLNG Oil/Gas Transmission
  • Sector
  • UNCY Health Care
  • SLNG Utilities
  • Exchange
  • UNCY Nasdaq
  • SLNG Nasdaq
  • Market Cap
  • UNCY 74.2M
  • SLNG 69.7M
  • IPO Year
  • UNCY 2021
  • SLNG N/A
  • Fundamental
  • Price
  • UNCY $3.94
  • SLNG $3.95
  • Analyst Decision
  • UNCY Strong Buy
  • SLNG Strong Buy
  • Analyst Count
  • UNCY 5
  • SLNG 1
  • Target Price
  • UNCY $55.20
  • SLNG $10.00
  • AVG Volume (30 Days)
  • UNCY 520.0K
  • SLNG 13.4K
  • Earning Date
  • UNCY 11-12-2025
  • SLNG 11-05-2025
  • Dividend Yield
  • UNCY N/A
  • SLNG N/A
  • EPS Growth
  • UNCY N/A
  • SLNG N/A
  • EPS
  • UNCY N/A
  • SLNG 0.05
  • Revenue
  • UNCY N/A
  • SLNG $69,572,000.00
  • Revenue This Year
  • UNCY N/A
  • SLNG $4.10
  • Revenue Next Year
  • UNCY $4,481.14
  • SLNG $11.10
  • P/E Ratio
  • UNCY N/A
  • SLNG $76.21
  • Revenue Growth
  • UNCY N/A
  • SLNG N/A
  • 52 Week Low
  • UNCY $3.40
  • SLNG $3.29
  • 52 Week High
  • UNCY $11.00
  • SLNG $8.28
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 37.53
  • SLNG 48.29
  • Support Level
  • UNCY $4.23
  • SLNG $3.48
  • Resistance Level
  • UNCY $4.43
  • SLNG $3.75
  • Average True Range (ATR)
  • UNCY 0.19
  • SLNG 0.23
  • MACD
  • UNCY -0.01
  • SLNG 0.01
  • Stochastic Oscillator
  • UNCY 22.22
  • SLNG 70.71

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: